tirzepatide serious side effects Explained: The Future of Weight Management Mounjaro (tirzepatide) side effects &

It is possible to lose weight with GLP-1 medications

In May 2025, a district court ruled that the FDA acted within its statutory authority in making that determination

Together, these capabilities form the demand-related basis required to realise oral GLP-1s full potential in the obesity treatment market

These professionals dont just write a prescription

However, CMS indicated that Medicare Part D can cover anti-obesity medications like Wegovy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight in guidance issued in March 2024